| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.53T | 660.39B | 656.94B | 663.15B | 658.26B |
| Gross Profit | 666.46B | 660.39B | 838.05B | 871.34B | 658.26B |
| EBITDA | 430.20B | 456.37B | 0.00 | 458.73B | 456.22B |
| Net Income | 359.02B | 365.86B | 363.99B | 361.13B | 348.34B |
Balance Sheet | |||||
| Total Assets | 53.50T | 48.82T | 44.70T | 39.61T | 35.17T |
| Cash, Cash Equivalents and Short-Term Investments | 4.74T | 6.97T | 5.30T | 4.74T | 4.19T |
| Total Debt | 10.28T | 2.60T | 1.90T | 912.97B | 1.28T |
| Total Liabilities | 49.50T | 44.83T | 40.92T | 36.09T | 31.90T |
| Stockholders Equity | 3.98T | 3.97T | 3.76T | 3.50T | 3.26T |
Cash Flow | |||||
| Free Cash Flow | 409.60B | 543.61B | 1.40T | 1.39T | 339.02B |
| Operating Cash Flow | 457.31B | 579.19B | 1.42T | 1.40T | 360.88B |
| Investing Cash Flow | -5.12T | -1.47T | -891.85B | -910.62B | -674.56B |
| Financing Cash Flow | 4.25T | 415.68B | 285.44B | -64.79B | -11.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.15T | 8.32 | 11.95% | 4.26% | -4.57% | 1.77% | |
77 Outperform | HK$2.25T | 5.23 | 9.77% | 5.64% | -4.61% | 0.94% | |
76 Outperform | HK$2.61T | 6.66 | 9.18% | 4.81% | -2.85% | 10.49% | |
75 Outperform | HK$1.96T | 5.41 | ― | 5.67% | -3.68% | 2.67% | |
70 Outperform | HK$2.88T | 5.61 | 9.18% | 5.46% | -3.35% | 0.58% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
57 Neutral | HK$649.92B | 6.72 | 9.30% | 5.37% | -1.54% | -3.95% |